ArticleBMC cancer2023

Management of metastatic melanoma in Texas: disparities in the utilization of immunotherapy following the regulatory approval of immune checkpoint inhibitors.

Olajumoke A Olateju et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.